The results we report further suggest that EP better captures the tumor-derived intrinsic factors that lead to distant metastasis in node-positive, ER+/HER2− disease compared with some of the clinicopathological markers traditionally used to make treatment decisions (age, grade, nodal status, tumor size, treatment arm, and ER and PR status and Ki67 index). This evidence concerns the gene ESR1 and neoplasm.